Post Profile

Rutgers Team Awarded Contract by CDC to Better Understand, Combat Multidrug Resistant Fungal Infections

A team at the Rutgers has won a $300,000 contract with the CDC to investigate emergence of antifungal drug resistance by the common fungal pathogen Candida glabrata. Fungal infections are a leading cause of morbidity and mortality among individuals with compromised immune systems. Treatment options are already highly limited.
read more


Related Posts

Novel algorithm predicts drug combinations to treat drug resistant fungal infections

Academics / General Science : ScienceDaily: Science Society

Scientists have created an algorithm that can identify drug combinations to treat fungal infections that have become resistant to current drug treatments. This new study represents a strategy for treating complex diseases and findin...

Highly drug resistant, virulent strain of Pseudomonas aeruginosa arises in Ohio

Academics / General Science : Science Codex

A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio. Their investigation suggests that the particular genetic element involve...

Researchers identify new class of antifungal agents

Academics / General Science : ScienceDaily: Science Society

A new class of antifungals has been identified, potentially useful to treat the more than 300 million people worldwide who develop serious fungal infections. Fungal infections are most commonly found in individuals with medical cond...

New anti-inflammatory agents can control inflammatory responses to fungal infection

Academics / General Science : ScienceDaily: Science Society

The most frequent fungal threat to humans, Candida albicans, is a common cause oral and genital infection. The fungal infections are often worsened by overwhelming inflammatory responses in the body and cause high mortality among ri...

Fatal fungal infections resist newest class of drugs

Academics / General Science : ScienceDaily: Science Society

Fungi that cause severe infections in those with compromised immune systems are resisting the action of the latest group of antifungal drugs. Uncovering their strategies for doing this will lead to more effective treatments, says a ...


Copyright © 2016 Regator, LLC